(Q24246411)

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Gabapentin for the treatment of pain in guillain-barré syndrome: a double-blinded, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Gabapentin in the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Is gabapentin a "Broad-spectrum" analgesic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Evidence for the use of gabapentin in the treatment of diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Open label gabapentin treatment for pain in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Anticonvulsants in neuropathic pain: rationale and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Gabapentin for neuropathic pain: systematic review of controlled and uncontrolled literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

The number needed to treat: a clinically useful measure of treatment effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Anticonvulsant drugs for acute and chronic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Neuropathic pain: aetiology, symptoms, mechanisms, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Anticonvulsant drugs for management of pain: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

Gabapentin vs amitriptyline for the treatment of peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

7 January 2021

Gabapentin therapy for diabetic neuropathic pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

7 January 2021

Gabapentin effect on spasticity in multiple sclerosis: a placebo-controlled, randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

7 January 2021

Clinical use of tricyclic anticonvulsants in painful neuropathies and bipolar disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

7 January 2021

Gabapentin for the treatment of spasticity in patients with spinal cord injury

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

7 January 2021

Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

7 January 2021

Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005452

7 January 2021